The genetics of ovarian cancer: Concepts in testing and counseling

Current Opinion in Obstetrics and Gynecology

Volumn 8, Issue 5, 1996, Pages 339-342

  Hartenbach, Ellen M ^a   Schink, Julian C ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CARCINOMA; CHROMOSOME 17Q; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; OVARY CARCINOMA; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW;

EID: 0029825429     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199610000-00003     Document Type: Review

References (16)

1. Kerlikowske K, Brown JS, Grady DG: Should women with familial ovarian cancer undergo prophylactic oophorectomy? Obstet Gynecol 1992, 80:700-707.
2. King MC, Rowell S, Love SM: Inherited breast and ovarian cancer. JAMA 1993, 269:1975-1980.
3. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W et al.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266:66-71.
4. Marra G, Boland CR: Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst 1995, 87:1114-1125.
5. Hall JM, Lee MK, Newman B, Morrow JE, Anderson LA, Huey B, King M-C: Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990, 250:1684-1689.
6. Szabo CI and King M-C: Inherited breast and ovarian cancer. Hum Mol Genet 1995, 4:1811-1817. A review of the inherited mutations in BRCA1, highlighting the specific genetic alterations with comments on preliminary clues to the function of the gene.
7. Shattuck-Eidens D, McClure M, Simard J, Labrie F, Narod S, Couch F, Hoskins K, Weber B, Castilla L, Erdos M et al.: A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. JAMA 1995, 273:535-541. Pooled information from nine laboratories describing the information on BRCA1-testing in 1086 women with breast or ovarian cancer. This paper outlines the characteristics of the mutations noted and the implications for pre-symptomatic testing and screening.
8. Easton DF, Ford D, Bishop T: Breast and ovarian cancer incidence in BRCA1 mutation carriers. Am J Hum Genet 1995, 56:265-271. Data from families with linkage to BRCA1 are analyzed to estimate age- specific risk of breast and ovarian cancer in mutation carriers.
9. Collins FS: BRCA1-lots of mutations, lots of dilemmas. N Engl J Med 1996, 334:186-188.
10. Fitzgerald MG, MacDonald DJ, Krainer M, Hoover I, O'Neil E, Unsal H, Silva-Arrieto S, Finkelstein DM, Beer-Romero P, Englert C et al.: Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 1996, 334:143-149. A BRCA1 mutation analysis of women less than 40 years of age demonstrated that germline BRCA1 mutations are present in women without a family history of breast cancer.
11. Struewing JP, Abeliovich D, Peretz T, Avishai N, Kaback, Collins FS, Brody LC: The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nature Genet 1995, 11:198-200.
12. Struewing JP, Lerman C, Kase RG, Giambarresi TR, Tucker MA: Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prevalence 1995, 4:169-173. This paper details a study of the interest in DNA testing for BRCA1 mutations in high-risk families: 79% of the subjects stated they 'definitely' would want to be tested and 16% 'probably' would want to be tested.
13. Lerman C, Daly M, Masny A, Balshem A: Attitudes about genetic testing for breast-ovarian cancer susceptibility. J Clin Oncol 1994, 12:843-850.
14. Kash KM, Holland JC, Halper MS, Miller DG: Psychological distress and surveillance behaviors of women with a family history of breast cancer. J Natl Cancer Inst 1992, 84:24-30.
15. Lerman C, Croyle RT: Emotional and behavioral responses to genetic testing for susceptibility to cancer. Oncology 1996, 10:191-199. This review focuses on the psychological impact of inherited cancer risk. Knowledge regarding the emotional responses to genetic testing and counseling necessary to provide such information is outlined.
16. National Institute of Health Consensus Conference: Ovarian cancer. JAMA 1995, 273:491-497.